Literature DB >> 6258916

Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside.

J L Tayot, J Holmgren, L Svennerholm, M Lindblad, M Tardy.   

Abstract

1. A receptor-specific affinity chromatographic method for large-scale purification of cholera toxin is described. The receptor ganglioside for cholera toxin, GM1, is hydrolysed to lysoGM1 which is then covalently coupled, via stabilized Schiff's bases, to porous silica beads (Spherosil) onto which a layer of DEAE-dextran has been adsorbed and cross-linked before coupling. Columns of these Spherosil-DEAE-dextran-lysoGM1 beads, in contrast to particles derivatized with lysoGA1, bound the cholera toxin of Vibrio cholerae culture filtrates, after which the toxin could be eluted with the aid of an acid citrate buffer (pH 2.8). 2. The toxin-binding capacity was directly proportional to the amount of lysoGM1 in the column: 2.3 mg/mu mol lysoGM1. The yield of purified toxin after acid elution and pH neutralization was essentially quantitative (83-107%). 3. The affinity-purified toxin contained less than 5% impurities, but consisted of a mixture of predominantly intact holotoxin and B subunit protomer which could readily be separated by gel filtration on Sephadex G-100. 4. Scaling up of the technique was possible: a 1 kg column enabled us to treat 1000-1 cultures of V. cholerae and thus to isolate 20 g of cholera toxin per cycle.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6258916     DOI: 10.1111/j.1432-1033.1981.tb05060.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  22 in total

1.  Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein.

Authors:  M T Dertzbaugh; D L Peterson; F L Macrina
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

2.  Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans.

Authors:  C Czerkinsky; A M Svennerholm; M Quiding; R Jonsson; J Holmgren
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

3.  Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.

Authors:  J Sanchez; J Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  Comparison of the reactivities and immunogenicities of procholeragenoid and the B subunit of cholera toxin in Thai volunteers.

Authors:  S Migasena; P Pitisuttitham; P Suntharasamai; B Prayurahong; W Supanaranond; V Desakorn; R E Black
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  Two-dimensional crystals of cholera toxin B-subunit-receptor complexes: projected structure at 17-A resolution.

Authors:  D S Ludwig; H O Ribi; G K Schoolnik; R D Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

6.  Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues.

Authors:  C Czerkinsky; M W Russell; N Lycke; M Lindblad; J Holmgren
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

7.  A potential epidemic factor from the bacteria, Vibrio cholerae WO7.

Authors:  Shalmoli Bhattacharyya; Jasleen Shant; Nirmal K Ganguly; Siddhartha Majumdar; Sujata Ghosh
Journal:  Curr Microbiol       Date:  2007-11-08       Impact factor: 2.188

8.  Changes in intestinal fluid and mucosal immune responses to cholera toxin in Giardia muris infection and binding of cholera toxin to Giardia muris trophozoites.

Authors:  I Ljungström; J Holmgren; A M Svennerholm; A Ferrante
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

9.  Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.

Authors:  R E Black; M M Levine; M L Clements; C R Young; A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

10.  Production of cholera toxin-like toxin by Vibrio mimicus and non-O1 Vibrio cholerae: batch culture conditions for optimum yields and isolation of hypertoxigenic lincomycin-resistant mutants.

Authors:  W M Spira; P J Fedorka-Cray
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.